Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial

Zohreh Mazloom, Abbas Yousefinejad, Mohammad Hossein Dabbaghmanesh, Zohreh Mazloom, Abbas Yousefinejad, Mohammad Hossein Dabbaghmanesh

Abstract

Background: The dramatic increase in the incidence of diabetes and its associated complications require a natural and safe solution to control and delay such complications. The present study tested the hypothesis that probiotics may affect biochemical indices of diabetic patients Methods: Thirty four types 2 diabetic patients aged between 25 to 65 years, and diagnosed with diabetes for less than 15 years were selected for this single- blinded clinical trial. Using balanced block random sampling, the patients were divided into two groups of intervention (probiotics) and placebo. Blood samples tested for baseline glucose, insulin, TG, total cholesterol, LDL-C, HDL-C, malondialdehyde, high sensitive CRP (hs-CRP) and IL-6. After six weeks of experiment, fasting blood samples were re-tested and the data obtained were analyzed using SPSS software.

Results: There were no significant differences between anthropometric data including body mass index and waist to hip ratio in placebo and treatment groups. There was no significant difference in FBS, Serum TG concentration total cholesterol and LDL-C levels between placebo and treatment groups. HDL-C levels were slightly elevated after probiotic treatment, which were not statistically significant. Insulin, MDA and IL-6 levels were reduced and high sensitive CRP hs.CRP levels were elevated, although, not statistically significant.

Conclusion: The result of this study indicates a non- significant declining trend in the level of TG, MDA and IL-6 and insulin resistance after consumption of probiotics.

Keywords: CRP; Diabetes; Insulin resistance; Probiotic.

References

    1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53. doi: 10.2337/diacare.27.5.1047. PubMed PMID: 15111519.
    1. Azimi-Nezhad M, Ghayour-Mobarhan M, Parizadeh MR, Safarian M, Esmaeili H, Parizadeh SM, et al. Prevalence of type 2 diabetes mellitus in Iran and its relationship with gender, urbanisation, education, marital status and occupation. Singapore Med J. 2008;49:571–6. PubMed PMID: 18695867.
    1. Voulgari C, Tentolouris N, Papadogiannis D, Moyssakis I, Perrea D, Kyriaki D, et al. Increased left ventricular arrhythmogenicity in metabolic syndrome and relationship with myocardial performance, risk factors for atherosclerosis, and low-grade inflammation. Metabolism. 2010;59:159–65. doi: 10.1016/j.metabol.2009.06.028. PubMed PMID: 19766273.
    1. Greenfield JR, Campbell LV. Relationship between inflammation insulin resistance and type 2 diabetes: ‘cause or effect’? Curr Diabetes Rev. 2006;2:195–211. doi: 10.2174/157339906776818532. PubMed PMID: 18220627.
    1. Diabetes and Aging. National Institute of Diabetes and Digestive and Kidney Diseases. Inc; c2002. [cited 2007 May 14]. Diabetes Dateline [Internet] Available from: .
    1. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia. 1997;40:1286–92. doi: 10.1007/s001250050822. PubMed PMID: 9389420.
    1. Voulgari Ch, Tentolouris N, Moyssakis I, Dilaveris P, Gialafos E, Papadogiannis D, et al. Spatial QRS-T angle: association with diabetes and left ventricular performance. Eur J Clin Invest. 2006;36:608–13. doi: 10.1111/j.1365-2362.2006.01697.x. PubMed PMID: 16919042.
    1. Pasupathi P, Chandrasekar V, Kumar US. Evaluation of oxidative stress, enzymatic and non-enzymatic antioxidants and metabolic thyroid hormone status in patients with diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2009;3:160–5. doi: 10.1016/j.dsx.2009.07.004.
    1. FAO/WHO [Internet] Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. c2001. [cited 2007 May 14]. Available from: .
    1. Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M, et al. Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem. 2003;67:1421–4. doi: 10.1271/bbb.67.1421. PubMed PMID: 12843677.
    1. Ali AA, Velasquez MT, Hansen CT, Mohamed AI, Bhathena SJ. Effects of soybean isoflavones, probiotics, and their interactions on lipid metabolism and endocrine system in an animal model of obesity and diabetes. J Nutr Biochem. 2004;15:583–90. doi: 10.1016/j.jnutbio.2004.04.005. PubMed PMID: 15542349.
    1. Calcinaro F, Dionisi S, Marinaro M, Candeloro P, Bonato V, Marzotti S, et al. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetologia. 2005;48:1565–75. doi: 10.1007/s00125-005-1831-2. PubMed PMID: 15986236.
    1. Fabian E, Elmadfa I. Influence of daily consumption of probiotic and conventional yoghurt on the plasma lipid profile in young healthy women. Ann Nutr Metab. 2006;50:387–93. doi: 10.1159/000094304. PubMed PMID: 16816529.
    1. Søndergaard D, Meyer O, Würtzen G. Magnesium stearate given perorally to rats A short term study. Toxicology. 1980;17:51–5. PubMed PMID: 7434368.
    1. U.S. Food and Drug Administration. USA: National Archives and Records Administration’s Electronic. Code of Federal Regulations. Inc; c2002. [cited 2002, Oct 22]. Available from: .
    1. Kumar M, Nagpal R, Kumar R, Hemalatha R, Verma V, Kumar A, et al. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp Diabetes Res. 2012;2012:902917. doi: 10.1155/2012/902917. PubMed PMID: 22611376; PubMed Central PMCID: PMC3352670.
    1. Mann GV, Spoerry A. Studies of a surfactant and cholesterolemia in the Maasai. Am J Clin Nutr. 1974;27:464–9.
    1. Yun SI, Park HO, Kang JH. Effect of Lactobacillus gasseri BNR17 on blood glucose levels and body weight in a mouse model of type 2 diabetes. J Appl Microbiol. 2009;107:1681–6. doi: 10.1111/j.1365-2672.2009.04350.x. PubMed PMID: 19457033.
    1. Gilliland SE, Walker DK. Factors to consider when selecting a culture of Lactobacillus acidophilus as a dietary adjunct to produce a hypocholesterolemic effect in humans. J Dairy Sci. 1990;73:905–11. doi: 10.3168/jds.S0022-0302(90)78747-4. PubMed PMID: 2111831.
    1. Gilliland SE, Nelson CR, Maxwell C. Assimilation of cholesterol by Lactobacillus acidophilus. Appl Environ Microbiol. 1985;49:377–81. PubMed PMID: 3920964; PubMed Central PMCID: PMC238411.
    1. Yadav H, Jain S, Sinha PR. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. J Dairy Res. 2008;75:189–95. doi: 10.1017/S0022029908003129. PubMed PMID: 18474136.
    1. Yadav H, Jain S, Sinha PR. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition. 2007;23:62–8. doi: 10.1016/j.nut.2006.09.002. PubMed PMID: 17084593.
    1. Del RioD, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005;15:316–28. doi: 10.1016/j.numecd.2005.05.003. PubMed PMID: 16054557.
    1. Ejtahed HS, Mohtadi-Nia J, Homayouni-Rad A, Niafar M, Asghari-Jafarabadi M, Mofid V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. 2012;28:539–43. doi: 10.1016/j.nut.2011.08.013. PubMed PMID: 22129852.
    1. Songisepp E, Kals J, Kullisaar T, Mändar R, Hütt P, Zilmer M, et al. Evaluation of the functional efficacy of an antioxidative probiotic in healthy volunteers. Nutr J. 2005;4:22. PubMed PMID: 16080791; PubMed Central PMCID: PMC1198254.
    1. Harisa GI, Taha EI, Khalil AF, Salem MM. Oral Administration of Lactobacillus Acidophilus Restores Nitric Oxide Level in Diabetic Rats. Aust J Basic and Appl Sci. 2009;3:2963–9.
    1. Lin MY, Chang FJ. Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig Dis Sci. 2000;45:1617–22. PubMed PMID: 11007114.
    1. Marschan E, Kuitunen M, Kukkonen K, Poussa T, Sarnesto A, Haahtela T, et al. Probiotics in infancy induce protective immune profiles that are characteristic for chronic low-grade inflammation. Clin Exp Allergy. 2008;38:611–8. doi: 10.1111/j.1365-2222.2008.02942.x. PubMed PMID: 18266878.
    1. Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scand J Rheumatol. 2003;32:211–5. doi: 10.1080/03009740310003695. PubMed PMID: 14626627.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj